Data sets, elements and combos paramaterized

This view should be used for custom for validation only.

dataset dataelement shortname code dataelementuid dataelementdesc categoryoptioncombo categoryoptioncombocode categoryoptioncombouid
Host Country Results: Narratives (USG) FY2018Q4 CXCA_SCRN (N, DSD_NARRATIVE): On ART screened for cervical cancer. CXCA_SCRN (N, DSD_NARRATIVE) CXCA_SCRN_N_DSD_NARRATIVE VRyFgVsVOQh Number of HIV-positive women on ART screened for cervical cancer default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 CXCA_SCRN (N, TA_NARRATIVE): On ART screened for cervical cancer. CXCA_SCRN (N, TA_NARRATIVE) CXCA_SCRN_N_TA_NARRATIVE ScXNe57YADJ Number of HIV-positive women on ART screened for cervical cancer default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 CXCA_TX (N, DSD_NARRATIVE): On ART eligible for treatment CXCA_TX (N, DSD_NARRATIVE) CXCA_TX_N_DSD_NARRATIVE ndREbLzsBVY Number of screen-positive women who are HIV-positive and on ART eligible for cryotherapy, LEEP, or thermocoagulation default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 DIAGNOSED_NAT (N, NAT_JUSTIFICATION): HIV Known Status DIAGNOSED_NAT (N, NAT_JUSTIFICATION) DIAGNOSED_NAT_N_NAT_JUSTIFICATION DuHErbNxlj8 Number of people living with HIV who know their status default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 DIAGNOSED_NAT (N, NAT_SOURCE): HIV Known Status DIAGNOSED_NAT (N, NAT_SOURCE) DIAGNOSED_NAT_N_NAT_SOURCE jXKCOKeZsMR Number of people living with HIV who know their status default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 EMR_SITE (N, NoApp_NARRATIVE): Services Offered EMR_SITE (N, NoApp_NARRATIVE) EMR_SITE_N_NoApp_NARRATIVE T8lqmZhVwib Do the following service delivery points supported by your organization have an electronic medical record? default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 FPINT_SITE (N, NoApp_NARRATIVE): Providing voluntary FPS FPINT_SITE (N, NoApp_NARRATIVE) FPINT_SITE_N_NoApp_NARRATIVE U0vgOuqBTZ0 Number of service delivery points supported by PEPFAR that are providing fully integrated voluntary family planning services default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 GEND_GBV (N, DSD_NARRATIVE): GBV Care GEND_GBV (N, DSD_NARRATIVE) GEND_GBV_N_DSD_NARRATIVE EsqYPXrhrFB Number of people receiving post-GBV care default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 GEND_GBV (N, TA_NARRATIVE): GBV Care GEND_GBV (N, TA_NARRATIVE) GEND_GBV_N_TA_NARRATIVE YGaA23XMrVN Number of people receiving post-GBV care default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 HRH_CURR (N, DSD_NARRATIVE): Health Workers HRH_CURR (N, DSD_NARRATIVE) HRH_CURR_N_DSD_NARRATIVE_CadreCategory XJyttYocAfx Total number of health care workers working in HIV service delivery at PEPFAR-supported clinical facility sites. Total will auto-calculate from the Cadre Disaggregates. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 HRH_PRE (N, NoApp_NARRATIVE): Graduates by Cadre HRH_PRE (N, NoApp_NARRATIVE) HRH_PRE_N_NoApp_NARRATIVE h1lqZhFcdk9 Number of new health workers who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 HRH_STAFF_NAT (N, NoApp_NARRATIVE): Health Workers HRH_STAFF_NAT (N, NoApp_NARRATIVE) HRH_STAFF_NAT_N_NoApp_NARRATIVE HIItkEzwIkc default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 HTS_SELF (N, DSD_NARRATIVE): HIV self test kits distributed HTS_SELF (N, DSD_NARRATIVE) HTS_SELF_N_DSD_NARRATIVE K1HrHLNWHTO Number of individual HIV self-test kits distributed. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 HTS_SELF (N, TA_NARRATIVE): HIV self test kits distributed HTS_SELF (N, TA_NARRATIVE) HTS_SELF_N_TA_NARRATIVE RgjxVO486yM Number of individual HIV self-test kits distributed. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 HTS_TST (N, DSD_NARRATIVE): HTS received results HTS_TST (N, DSD_NARRATIVE) HTC_TST_N_DSD_NARRATIVE NojQhMhlNr1 Number of individuals who received HTC services and received their test results during the PEPFAR reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 HTS_TST (N, TA_NARRATIVE): HTS received results HTS_TST (N, TA_NARRATIVE) HTC_TST_N_TA_NARRATIVE qSGw5MTLMu0 Number of individuals who received HTC services and received their test results during the PEPFAR reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 KP_MAT_NAT (N, NAT_JUSTIFICATION): PWID on MAT KP_MAT_NAT (N, NAT_JUSTIFICATION) KP_MAT_N_NAT_JUSTIFICATION C69dgjR70gJ Number of people who inject drugs (PWID) on MAT default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 KP_MAT_NAT (N, NAT_SOURCE): PWID on MAT KP_MAT_NAT (N, NAT_SOURCE) KP_MAT_N_NAT_SOURCE gpGRHAMJeHV Number of people who inject drugs (PWID) on MAT default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 KP_MAT (N, DSD_NARRATIVE): PWID on MAT KP_MAT (N, DSD_NARRATIVE) KP_MAT_N_DSD_NARRATIVE ex6eAUl6GzQ Number of people who inject drugs (PWID) who are receiving medication assisted therapy (MAT). default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 KP_MAT (N, TA_NARRATIVE): PWID on MAT KP_MAT (N, TA_NARRATIVE) KP_MAT_N_TA_NARRATIVE sqkTC98ZUZY Number of people who inject drugs (PWID) who are receiving medication assisted therapy (MAT). default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 KP_PREV (N, DSD_NARRATIVE): Key Pop Preventive KP_PREV (N, DSD_NARRATIVE) KP_PREV_N_DSD_NARRATIVE bt46nTPTQBL Number of key populations reached with individual and/or small group level preventive interventions that are based on evidence and/or meet the minimum standards required default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 KP_PREV (N, TA_NARRATIVE): Key Pop Preventive KP_PREV (N, TA_NARRATIVE) KP_PREV_N_TA_NARRATIVE CC9lo9sZjyl Number of key populations reached with individual and/or small group level preventive interventions that are based on evidence and/or meet the minimum standards required default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 LAB_PTCQI (N, NoApp_NARRATIVE): LabSurvey LAB_PTCQI (N, NoApp_NARRATIVE) LAB_PTCQI_N_NoApp_NARRATIVE X4DAPtMbi0S Accreditation default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 MER_OU (N, DSD_NARRATIVE): OU Narratives MER_OU (N, DSD_NARRATIVE) MER_OU_N_DSD_NARRATIVE PBUqI3WuIbG default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 OVC_HIVSTAT (N, DSD_NARRATIVE): OVC Disclosed Known HIV Status OVC_HIVSTAT (N, DSD_NARRATIVE) OVC_HIVSTAT_N_DSD_NARRATIVE g7ul7rxoRM8 Number of OVC with HIV status reported to implementing partner (including status not reported). default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 OVC_HIVSTAT (N, TA_NARRATIVE): OVC Disclosed Known HIV Status OVC_HIVSTAT (N, TA_NARRATIVE) OVC_HIVSTAT_N_TA_NARRATIVE NAoTY9iRJvD Number of OVC with HIV status reported to implementing partner (including status not reported). default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 OVC_SERV (N, DSD_NARRATIVE): Beneficiaries Served OVC_SERV (N, DSD_NARRATIVE) OVC_SERV_N_DSD_NARRATIVE NQVaE97nszA Number of active beneficiaries served by PEPFAR programs for children and families affected by HIV/AIDS. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 OVC_SERV (N, TA_NARRATIVE): Beneficiaries Served OVC_SERV (N, TA_NARRATIVE) OVC_SERV_N_TA_NARRATIVE ugtQ8oTUjgO Number of active beneficiaries served by PEPFAR programs for children and families affected by HIV/AIDS. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_ART_NAT (N, NAT_JUSTIFICATION): ART PMTCT_ART_NAT (N, NAT_JUSTIFICATION) PMTCT_ARV_N_NAT_JUSTIFICATION BdsGxALDp50 Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_ART_NAT (N, NAT_SOURCE): ART PMTCT_ART_NAT (N, NAT_SOURCE) PMTCT_ARV_N_NAT_SOURCE MaVWcd4hrcn Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_ART (N, DSD_NARRATIVE): ART PMTCT_ART (N, DSD_NARRATIVE) PMTCT_ARV_N_DSD_NARRATIVE uhJjqcYppn9 Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission during pregnancy. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_ART (N, TA_NARRATIVE): ART PMTCT_ART (N, TA_NARRATIVE) PMTCT_ARV_N_TA_NARRATIVE IXLoHy08ab5 Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission during pregnancy. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_EID (N, DSD_NARRATIVE): Infant Testing PMTCT_EID (N, DSD_NARRATIVE) PMTCT_EID_N_DSD_NARRATIVE xK8FRowHWuo Number of infants who had a virologic HIV test within 12 months of birth during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_EID (N, TA_NARRATIVE): Infant Testing PMTCT_EID (N, TA_NARRATIVE) PMTCT_EID_N_TA_NARRATIVE acSAmCbEofz Number of infants who had a virologic HIV test within 12 months of birth during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_FO (N, DSD_NARRATIVE): Final Outcomes Exposed Infants PMTCT_FO (N, DSD_NARRATIVE) PMTCT_FO_N_DSD_NARRATIVE wgpgPAAFsZm Number of HIV-exposed infants with a documented outcome by 18 months of age disaggregated by outcome type. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_FO (N, TA_NARRATIVE): Final Outcomes Exposed Infants PMTCT_FO (N, TA_NARRATIVE) PMTCT_FO_N_TA_NARRATIVE FNFPRTrkzKa Number of HIV-exposed infants with a documented outcome by 18 months of age disaggregated by outcome type. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_HEI_POS (N, DSD_NARRATIVE): Infant Testing PMTCT_HEI_POS (N, DSD_NARRATIVE) PMTCT_HEI_POS_N_DSD_NARRATIVE Rvd2pHCkd4l Number of HIV-infected infants identified in the reporting period, whose diagnostic sample was collected by 12 months of age. Excludes confirmatory testing. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_HEI_POS (N, TA_NARRATIVE): Infant Testing PMTCT_HEI_POS (N, TA_NARRATIVE) PMTCT_HEI_POS_N_TA_NARRATIVE X3J2tKb7lpP Number of HIV-infected infants identified in the reporting period, whose diagnostic sample was collected by 12 months of age. Excludes confirmatory testing. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_STAT_NAT (N, NAT_JUSTIFICATION): Known Results PMTCT_STAT_NAT (N, NAT_JUSTIFICATION) PMTCT_STAT_N_NAT_JUSTIFICATION U1xYsN8orjv Number of pregnant women who were tested for HIV and know their results plus number of pregnant women with known HIV status at entry to services. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_STAT_NAT (N, NAT_SOURCE): Known Results PMTCT_STAT_NAT (N, NAT_SOURCE) PMTCT_STAT_N_NAT_SOURCE DJ0OT404DbA Number of pregnant women who were tested for HIV and know their results plus number of pregnant women with known HIV status at entry to services. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_STAT (N, DSD_NARRATIVE): Known Results PMTCT_STAT (N, DSD_NARRATIVE) PMTCT_STAT_N_DSD_NARRATIVE PbzlDpo6Nqm Number of pregnant women with known HIV status (includes those who already knew their HIV status prior to ANC) default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PMTCT_STAT (N, TA_NARRATIVE): Known Results PMTCT_STAT (N, TA_NARRATIVE) PMTCT_STAT_N_TA_NARRATIVE EaiyFkPh5Lw Number of pregnant women with known HIV status (includes those who already knew their HIV status prior to ANC) default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PP_PREV (N, DSD_NARRATIVE): HIV Prevention Program PP_PREV (N, DSD_NARRATIVE) GPY_PREV_N_DSD_NARRATIVE saxOfAUSLQI Number of each priority population who completed a standardized HIV prevention program including the specified minimum components during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PP_PREV (N, TA_NARRATIVE): HIV Prevention Program PP_PREV (N, TA_NARRATIVE) GPY_PREV_N_TA_NARRATIVE ZxzVHfKLIxF Number of each priority population who completed a standardized HIV prevention program including the specified minimum components during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PrEP_NEW (N, DSD_NARRATIVE): Newly Enrolled PrEP PrEP_NEW (N, DSD_NARRATIVE) PrEP_NEW_N_DSD_NARRATIVE Z0z4smSdCtO Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 PrEP_NEW (N, TA_NARRATIVE): Newly Enrolled PrEP PrEP_NEW (N, TA_NARRATIVE) PrEP_NEW_N_TA_NARRATIVE YHn9gXE57PE Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 SC_STOCK (N, DSD_NARRATIVE): Between Min-Max SC_STOCK (N, DSD_NARRATIVE) SC_STOCK_N_DSD_NARRATIVE SKg8eZtdaQE Number of stock status observations for one or more tracer commodities that are between the designed minimum and maximum quantities/months of stock from storage sites at a given level default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 SC_STOCK (N, TA_NARRATIVE): Between Min-Max SC_STOCK (N, TA_NARRATIVE) SC_STOCK_N_TA_NARRATIVE As0948DMuLS Number of stock status observations for one or more tracer commodities that are between the designed minimum and maximum quantities/months of stock from storage sites at a given level default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TB_ART (N, DSD_NARRATIVE): TB/HIV on ART TB_ART (N, DSD_NARRATIVE) TB_ART_N_DSD_NARRATIVE B0uV7upkFAa Number of TB cases with documented HIV-positive status who start or continue ART during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TB_ART (N, TA_NARRATIVE): TB/HIV on ART TB_ART (N, TA_NARRATIVE) TB_ART_N_TA_NARRATIVE NPf6yerWbum Number of TB cases with documented HIV-positive status who start or continue ART during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TB_PREV (N, DSD_NARRATIVE): IPT TB_PREV (N, DSD_NARRATIVE) TB_PREV_N_DSD_NARRATIVE QNKcsBg0QT3 Number of ART patients who completed a course of TB preventive therapy during the reporting period (for continuous IPT programs, this includes the patients who have completed the first 6 months of isoniazid preventive therapy (IPT)) default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TB_PREV (N, TA_NARRATIVE): IPT TB_PREV (N, TA_NARRATIVE) TB_PREV_N_TA_NARRATIVE YA2gScalJLZ Number of ART patients who completed a course of TB preventive therapy during the reporting period (for continuous IPT programs, this includes the patients who have completed the first 6 months of isoniazid preventive therapy (IPT)) default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TB_STAT (N, DSD_NARRATIVE): New/Relapsed TB with HIV TB_STAT (N, DSD_NARRATIVE) TB_STAT_N_DSD_NARRATIVE xpD4rLojvp3 Number of registered new and relapsed TB cases with documented HIV status, during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TB_STAT (N, TA_NARRATIVE): New/Relapsed TB with HIV TB_STAT (N, TA_NARRATIVE) TB_STAT_N_TA_NARRATIVE ZJxIpL73lHA Number of registered new and relapsed TB cases with documented HIV status, during the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_CURR_NAT (N, NAT_JUSTIFICATION): Receiving ART TX_CURR_NAT (N, NAT_JUSTIFICATION) TX_CURR_N_NAT_JUSTIFICATION Pv84QqOdUp9 Number of adults and children who are currently receiving ART in accordance with the nationally approved treatment protocol (or WHO/UNAIDS standards) at the end of the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_CURR_NAT (N, NAT_SOURCE): Receiving ART TX_CURR_NAT (N, NAT_SOURCE) TX_CURR_N_NAT_SOURCE yQYeoobPoEX Number of adults and children who are currently receiving ART in accordance with the nationally approved treatment protocol (or WHO/UNAIDS standards) at the end of the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_CURR (N, DSD_NARRATIVE): Receiving ART TX_CURR (N, DSD_NARRATIVE) TX_CURR_N_DSD_NARRATIVE g2s6jffBGVo Number of adults and children currently receiving antiretroviral therapy (ART) default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_CURR (N, TA_NARRATIVE): Receiving ART TX_CURR (N, TA_NARRATIVE) TX_CURR_N_TA_NARRATIVE XNGegkN06Hg Number of adults and children currently receiving antiretroviral therapy (ART) default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_NEW (N, DSD_NARRATIVE): New on ART TX_NEW (N, DSD_NARRATIVE) TX_NEW_N_DSD_NARRATIVE vEAQud3la1j Number of adults and children newly enrolled on antiretroviral therapy (ART) default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_NEW (N, TA_NARRATIVE): New on ART TX_NEW (N, TA_NARRATIVE) TX_NEW_N_TA_NARRATIVE ygw0mTq5ghj Number of adults and children newly enrolled on antiretroviral therapy (ART) default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_PVLS (N, DSD_NARRATIVE): 12 Months Viral Load < 1000 TX_PVLS (N, DSD_NARRATIVE) TX_PVLS_N_DSD_NARRATIVE xhQ5DYdoEtm Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and/or supporting laboratory results within the past 12 months. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_PVLS (N, TA_NARRATIVE): 12 Months Viral Load < 1000 TX_PVLS (N, TA_NARRATIVE) TX_PVLS_N_TA_NARRATIVE Kso2fsfhGG8 Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and/or supporting laboratory results within the past 12 months. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_RET (N, DSD_NARRATIVE): Alive at 12 mo. after initiating ART TX_RET (N, DSD_NARRATIVE) TX_RET_N_DSD_NARRATIVE jzG5uXvzj4j Number of adults and children who are still alive and on treatment at 12, 24, and 36 months after initiating ART default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_RET (N, TA_NARRATIVE): Alive at 12 mo. after initiating ART TX_RET (N, TA_NARRATIVE) TX_RET_N_TA_NARRATIVE Noextsqncku Number of adults and children who are still alive and on treatment at 12, 24, and 36 months after initiating ART default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_TB (N, DSD_NARRATIVE): TB Screening TX_TB (N, DSD_NARRATIVE) TX_TB_N_DSD_NARRATIVE CAG5cD4OdyD Number of ART patients who were started on TB treatment during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 TX_TB (N, TA_NARRATIVE): TB Screening TX_TB (N, TA_NARRATIVE) TX_TB_N_TA_NARRATIVE yO4KTgQz6Yg Number of ART patients who were started on TB treatment during the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 VL_SUPPRESSION_NAT (N, NAT_JUSTIFICATION): Suppressed Viral Load VL_SUPPRESSION_NAT (N, NAT_JUSTIFICATION) VL_SUPPRESSION_NAT_N_NAT_JUSTIFICATION PqJI7bYcgY4 Number of adults and children receiving antiretroviral therapy in the reporting period with suppressed viral load (i.e. <=1000 copies) default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 VL_SUPPRESSION_NAT (N, NAT_SOURCE): Suppressed Viral Load VL_SUPPRESSION_NAT (N, NAT_SOURCE) VL_SUPPRESSION_NAT_N_NAT_SOURCE SWoLL0NydVU Number of adults and children receiving antiretroviral therapy in the reporting period with suppressed viral load (i.e. <=1000 copies) default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 VMMC_CIRC_NAT (N, NAT_JUSTIFICATION): Voluntary Circumcised VMMC_CIRC_NAT (N, NAT_JUSTIFICATION) VMMC_CIRC_N_NAT_JUSTIFICATION opU2oNiWSYz Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 VMMC_CIRC_NAT (N, NAT_SOURCE): Voluntary Circumcised VMMC_CIRC_NAT (N, NAT_SOURCE) VMMC_CIRC_N_NAT_SOURCE tmMV8D394zM Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 VMMC_CIRC (N, DSD_NARRATIVE): Voluntary Circumcised VMMC_CIRC (N, DSD_NARRATIVE) VMMC_CIRC_N_DSD_NARRATIVE XDFcXsXkFmY Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 VMMC_CIRC (N, TA_NARRATIVE): Voluntary Circumcised VMMC_CIRC (N, TA_NARRATIVE) VMMC_CIRC_N_TA_NARRATIVE jR9IhB0sLmT Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period. default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 VMMC_TOTALCIRC_NAT (N, NAT_JUSTIFICATION): Voluntary Circumcised VMMC_TOTALCIRC_NAT (N, NAT_JUSTIFICATION) VMMC_TOTALCIRC_NAT_N_NAT_JUSTIFICATION acQwqrGTSKq Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period default HllvX50cXC0 HllvX50cXC0
Host Country Results: Narratives (USG) FY2018Q4 VMMC_TOTALCIRC_NAT (N, NAT_SOURCE): Voluntary Circumcised VMMC_TOTALCIRC_NAT (N, NAT_SOURCE) VMMC_TOTALCIRC_NAT_N_NAT_SOURCE SMLRuCiu7in Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period default HllvX50cXC0 HllvX50cXC0